Comment
doi: 10.1200/JCO.2014.57.9227.
Epub 2014 Sep 29.
Reply to S. Barni et Al and M. Sun et Al
Affiliations
- PMID: 25267752
- DOI: 10.1200/JCO.2014.57.9227
Item in Clipboard
Comment
Reply to S. Barni et Al and M. Sun et Al
J Clin Oncol.
.
No abstract available
Comment on
-
Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study.J Clin Oncol. 2014 May 10;32(14):1412-8. doi: 10.1200/JCO.2013.50.8267. Epub 2014 Mar 31. J Clin Oncol. 2014. PMID: 24687826 Clinical Trial.
-
PISCES: a horoscope for first-line targeted therapy of metastatic renal cell carcinoma.J Clin Oncol. 2014 Nov 20;32(33):3783. doi: 10.1200/JCO.2014.57.4673. Epub 2014 Sep 29. J Clin Oncol. 2014. PMID: 25267763 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
